{"id":772231,"date":"2023-07-25T10:16:31","date_gmt":"2023-07-25T14:16:31","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/"},"modified":"2023-07-25T10:16:31","modified_gmt":"2023-07-25T14:16:31","slug":"biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/","title":{"rendered":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications"},"content":{"rendered":"<h2>\nDeal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders<br \/>\n<\/h2>\n<div class=\"mw_release\">\n<p>Westport, CT, July  25, 2023  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q3jKRpjxEGKM_xdv7_ojl6mumsbJSc0NE4hyzOQsb7uWvhfpWcHaPiz-MkrmhUeMNtrAdQiPEBHYrDySQyDLaz_021Q_s29bRMLoa0vMIyM=\" rel=\"nofollow noopener\" target=\"_blank\"><u>BioSig Technologies, Inc.<\/u><\/a> (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (\u201cBAIS\u201d), a subsidiary of the Company. BAIS intends to join BioSig\u2019s world class technology team with external partners and collaborators to advance the research and development of an artificial intelligence (\u201cAI\u201d) medical device platform. <\/p>\n<p>\u201cThe integration of AI and machine learning in electrophysiology devices is powering substantial expected growth for this market, and we intend to be a leader in developing applications of these technologies,\u201d said Ken Londoner, Chairman, CEO and Founder of BioSig. \u201cOur current platform and relationships have created interest and excitement and our development team are making demonstrations for early adopters\u201d added Londoner.<\/p>\n<p>BioSig and Reified Labs\u2019 initial AI collaboration, which began in 2019, has resulted in multiple patent applications to date and a research publication on AI-enhanced electrocardiogram lead placement mapping. The renewed collaboration, BAIS, is also looking into the application of Chat-GPT like large language models and how they apply to helping our hospital partners leverage such technology to solve the myriad of challenges they currently face.<\/p>\n<p>According to Data Bridge Market Research, the market for artificial intelligence in healthcare, estimated at $9.6 billion in 2022, is expected to reach $272.9 billion by 2030, at a CAGR of 51.9% during the forecast period.<sup>1\u00a0<\/sup><\/p>\n<p>\n        <strong>About BAIS<\/strong><br \/>\n        <br \/>BAIS, a majority-owned Delaware C Corporation subsidiary of BioSig, is developing AI solutions for the hospital marketplace utilizing structured, semi-structured, and unstructured data.<\/p>\n<p>\n        <strong>About BioSig Technologies<\/strong><br \/>\n        <br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Q3jKRpjxEGKM_xdv7_ojl2jq7aySlHqdgflDU8hOtztLdNbRu724tUZgTSYmbnm6rrfItWguzvt2tShoNx0nFgpb-UVHFBddWtCWLIvMO9tFFPixzopGINtDnXaJ038SqwYP3oqaa0mIQUz18w7p4IoQs17VrUL5qG-isw9eJgf82Srn9CuJCp6PbvrHWvQ8XQBfJrM-rmDYDkOXa317cwuAruJYk7KU06sS9KkinF8mT8CstDJcLxIjf2dXqfMc94WVzKoGtsPb4yXf6BN9RM7b6YpMCNEA21kEE_SNG07SwvTscClNl2XBCJ_0zYzEnv3kZBzFCodmcXN4o0zTXxcHGkp41WIQWXjdIeCC0RRUI7VP52Rym-yanke-F8sikKHZpmHTaaEUg0vyXAsZ8hn0S4UAZNnQCLIKLKmcl8qktODtIjE7Vm-5015rMhKQF1Fs_bHhKKiWTNN19uqyZcFaCyix6Sg1mnkp0z_lDjZTDK4vOTjzT_tSgN__Ah9Y3HhUXulcPIQ4fDQWXPvLxQ7z3Z-Xd15RuhxN9AVuM5DSiO3A7PUCYHaYbjUpnD8uZ3tggUW8Y89J02pC3nWVdWZ6XFwutC1wqCIryCgLX3o1sxnXw-25Yir3p9kWEiObsfu4KFx3Um8LzUmujdAH98Fn_S_b_TqshuZFQDcZBaNVmvvO5LyftFKMWe3mKwi4Al0AbuRDs0KWo0lQ3oxq2yT24KcbUkTyjV7WdrEfL9zQ3rOasAtmolkjS8GVeaYU1h8xzlSD5lBiwhlqbplrJA==\" rel=\"nofollow noopener\" target=\"_blank\">BioSig Technologies<\/a>\u00a0is an advanced medical technology company bringing never-before-seen insights to the treatment of cardiovascular arrhythmias. Through collaboration with physicians, experts, and healthcare leaders across the field of electrophysiology (EP), BioSig is committed to addressing healthcare\u2019s biggest priorities\u2014saving time, saving costs, and saving lives.<\/p>\n<p>The Company\u2019s first product, the PURE EP\u2122 Platform, an FDA 510(k) cleared non-invasive class II device, provides superior, real-time signal visualization allowing physicians to perform insight-based, highly targeted cardiac ablation procedures with increased procedural efficiency and efficacy.<\/p>\n<p>The global EP market is projected to reach $16B in 2028 with an 11.2% growth rate.<sup>2<\/sup><\/p>\n<p>\n        <strong><br \/>\n          <br \/>\n        <\/strong>\n      <\/p>\n<p>\n        <strong>Forward-looking Statements<\/strong><br \/>\n        <br \/> This press release contains \u201cforward-looking statements.\u201d Such statements may be preceded by the words \u201cintends,\u201d \u201cmay,\u201d \u201cwill,\u201d \u201cplans,\u201d \u201cexpects,\u201d \u201canticipates,\u201d \u201cprojects,\u201d \u201cpredicts,\u201d \u201cestimates,\u201d \u201caims,\u201d \u201cbelieves,\u201d \u201chopes,\u201d \u201cpotential\u201d or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company\u2019s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) the geographic, social and economic impact of COVID-19 on our ability to conduct our business and raise capital in the future when needed, (ii) our inability to manufacture our products and product candidates on a commercial scale on our own, or in collaboration with third parties; (iii) difficulties in obtaining financing on commercially reasonable terms; (iv) changes in the size and nature of our competition; (v) loss of one or more key executives or scientists; and (vi) difficulties in securing regulatory approval to market our products and product candidates. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company\u2019s filings with the Securities and Exchange Commission (SEC), including the Company\u2019s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=DYYelecK1zWIN1UBrkpvKypgKJ3vy7PwnMCe8D9-6q9amDmguwEryx-W-rzSOYaw_4EXQyth0tt2oh-mbeZP4sBzB8e3EVJ2FA-U2tNGpHqhaHuwzW0I3LnPLGuGVe-Xymtec5ArKgtyczg1RYUQGlBAcbLb_uLly2uhqN7v6KfrGg5ugVms7S4gcmZ7pOwWc8oeaF9-n1Q_SPwYe4MUTqdozHknkxYgXU4K6prx5pCkdiUzgKPJM7_6xDf4PXPZb86Is_dYoxQebAq_A0mYNWnmWMKyrWdmOYTMG1CXydzBGxEZM4Nh5D8bdq4QMGLe_m8mCo-CzUT8CbFuirVxPAq4UC_Nw4CniVUJAFRcI6yrVp6qEekkh2OTPLl2rIbTiM9vEMx_ezmP4oLagAAmFzp_LhD0IRN7wlv6BLk-IHzLM0NabU_3p1aZnJp9ONbc0iUmnFjwBjo2fXG9GVoupw4fO2XqMauoG9-HY2I6AIxn6NSQVKdZ-A1-psDR90CXOVPtNk1vhIu2BSckrQghsgqW5lJdc6wZ-PtYgMmPySZI8sMc_jEjNsO1ug1xIxekcP3DW1I963fLoELAcyLEVtUwKEzyJNWN0Hq0qRpFiMa40g_r3a6PC5LJWQEREqFlA1rLdk9dDyBnFSkl3hO_uWqKlRZf0q_CD_LecJ6Y3zVY-hBa5cwhqItLlzvh15PicKQMYwJHqDoMEEFUP9_f8rxxV5Bp_rV6bftw9nrnu39IeELLh7bixERsuipGx6_rQJPggW-Gqskhgr1heXdhlm9W4IBrJSkXK9Z9ubrrhKQ4JsbfFI6uLM0RUpyWdn3oiK_SOcq1qBZQxv_u5i2gdd3y4bbVhFa_K3fmB1VSdnYb59BZ06JDVy-aEBa8zRO2lRWEskhDsVvPd0YUoSrlhXtujAOIk5J9kSQ2kWLhQ9792qLK7Xzrg8QI7F4jhiiIiO0_vif5SLuejqam27fVGW5gPm9Ga_k_IL2dk5HwILdh2Vt_vvTOd7wUwgpVCwMeczOEsl8BK4KkdEmVHfzhWMowvWJHyJjqi5hPdb0bAVmcR4nju_oavkwXOZ_x9UTQqeNzhYQQFVlKxE68U9_3_R-wUI9UqHC2gLjEH8SSsvN9uA3OwvOuz4qJVYG7L02Hx5obyDvQUY7ZNm6keZ8-dVq9cQPFlKgUwJgJDf0vXylYTkrWIkhGtzGN00IOY5D4k7BLfQiaE9f0jdtbtKtxRiFAPbuYqqi45XXCpSKrmUHMdOYeJ5hQsryzYT0UsNE71Yd-yMkcBi4TCsCr4lSX2cdNzFPZ9bsigDAyg-9gk60dBQa5-zX6kq_TqUPC7J6AsxhAMAfmbG9ncpO3pizmVXtlbKGmR_w56T8NP1xOWzflE20QnVk22sp8WX6J_6uQXpIa4YsJ0iXOqo6aeeLU0KNJJEfqL9b-L7_jAlHccTVHGi5FtqsoD7Nht_M9EFYu5LsV_95hY7Z5dbga2jSkDJbmy-xWa1AIE2v6m-Qtdrip1i-oxxpWKkW58VrFQO1OFSyu5CL2UeaUcCk_xbuNoJUlpFZTeYLliLQPdO746BoZMrN53liA_L8IbkFDZPOgBGpWhlcdMEgOWZ4A7isgyeFzgsT8XZarOif26fbeJSFKHYIWDwrK4mrYNzjZRnSEuP9BUfg7v_tFPRKmIH1Ic1oxlS2qJ_hjMLHq_QH6Jv59P9r2wV2iUELeVDqsjrbRaB4JddHTVXXLHUpHfVqOuvos07j67ejbKBQdZOgQ_PwUANyN7Svr-2VIbuCppyaiuucmCyQpwU_ESVkEksXaLuSh6pI2iyxUqpJOJMrSXE3N1z3L63-A2dP3E--PKsFNBJgbWLyS-Fhrb5T0L-F1x5LOXfhDn_wCAFAouL_uSLQXOXWwBwrPjSlXJ4iAidJ0cb-ff9HMfHMfY_B93pxPH45eAG1HdmT0ONZaliqMQxUvjvq9rEf47fIazdShzLlYECXBC2a2zjcPJYoSa_s273SYRHLCkhdhQzIKttjmCm2yBVZ3_peN3VMiMcq1X1QkORLs2GndaqRCkiAxIkgbftQ-4PDye2cdj_M4N5EREz2QWCwNdVjJlU9KgwdM-LOB\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.sec.gov<\/a>. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.<\/p>\n<hr \/>\n<p>\n        <sub><br \/>\n          <sup>1<\/sup><br \/>\n        <\/sub>\u00a0Data Bridge Market Research. Global Artificial Intelligence in Healthcare Market \u2013 Industry Trends and Forecast to 2030. January 2023. <\/p>\n<p>\n        <sup>2<\/sup>\u00a0 Global Market Insights Inc. March 08, 2022<\/p>\n<p>\n        \n      <\/p>\n<\/p>\n<hr \/>\n<p>\n        <b><br \/>\n          <br \/>\n        <\/b>\n      <\/p>\n<p>\n        \n      <\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OGEyODBhZWItMmMwNS00N2RlLTk1MTMtYjhiMGJjYTMzYWU0LTEwMjk2NDk=\/tiny\/BioSig-Technologies-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\">\n<pre>Andrew Ballou\r\nBioSig Technologies, Inc. \r\nVice President, Investor Relations \r\n55 Greens Farms Road\r\nWestport, CT 06880\r\naballou@biosigtech.com\r\n203-409-5444, x133\r\n\r\n<\/pre>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Deal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (\u201cBAIS\u201d), a subsidiary of the Company. BAIS intends to join BioSig\u2019s world class technology team with external partners and collaborators to advance the research and development of an artificial intelligence (\u201cAI\u201d) medical device platform. \u201cThe integration of AI and machine learning in electrophysiology devices is powering substantial expected growth for this market, and we intend &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-772231","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Deal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (\u201cBAIS\u201d), a subsidiary of the Company. BAIS intends to join BioSig\u2019s world class technology team with external partners and collaborators to advance the research and development of an artificial intelligence (\u201cAI\u201d) medical device platform. \u201cThe integration of AI and machine learning in electrophysiology devices is powering substantial expected growth for this market, and we intend &hellip; Continue reading &quot;BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T14:16:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications\",\"datePublished\":\"2023-07-25T14:16:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/\"},\"wordCount\":702,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/\",\"name\":\"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\",\"datePublished\":\"2023-07-25T14:16:31+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/","og_locale":"en_US","og_type":"article","og_title":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk","og_description":"Deal to create additional value through subsidiary to advance Artificial Intelligence strategy without dilution to BioSig Technologies Shareholders Westport, CT, July 25, 2023 (GLOBE NEWSWIRE) &#8212; BioSig Technologies, Inc. (NASDAQ: BSGM) (\u201cBioSig\u201d or the \u201cCompany\u201d), a medical technology company delivering unprecedented accuracy and precision to intracardiac signal visualization, today announced the completion of a seed funding round raising $2.2 million for BioSig AI Sciences, Inc. (\u201cBAIS\u201d), a subsidiary of the Company. BAIS intends to join BioSig\u2019s world class technology team with external partners and collaborators to advance the research and development of an artificial intelligence (\u201cAI\u201d) medical device platform. \u201cThe integration of AI and machine learning in electrophysiology devices is powering substantial expected growth for this market, and we intend &hellip; Continue reading \"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/","og_site_name":"Market Newsdesk","article_published_time":"2023-07-25T14:16:31+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications","datePublished":"2023-07-25T14:16:31+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/"},"wordCount":702,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/","name":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=","datePublished":"2023-07-25T14:16:31+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg3OTkzNSM1NzA3MTk1IzIwMTgwNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/biosig-ai-sciences-receives-2-2-million-in-seed-funding-to-advance-development-of-artificial-intelligence-applications\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"BioSig AI Sciences Receives $2.2 Million in Seed Funding to Advance Development of Artificial Intelligence Applications"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772231","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=772231"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/772231\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=772231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=772231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=772231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}